SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000908662-13-000324
Filing Date
2013-12-13
Accepted
2013-12-13 18:34:50
Documents
1
Period of Report
2013-12-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 7005
  Complete submission text file 0000908662-13-000324.txt   8463
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Issuer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SORRENTO THERAPEUTICS, INC. 6042 CORNERSTONE CT., SUITE B SAN DIEGO CA 92121
Business Address
AFTING ERNST-GUENTER (Reporting) CIK: 0001234864 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35839 | Film No.: 131277398